Evidence map›Paper›PMID 12707849›Full record

ReviewJournal of neurovirology2003

Prion diseases.

Edward McKintosh, Sarah J Tabrizi, John Collinge

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neurovirology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.Wiener klinische Wochenschrift · 2004
    Trial
  2. Review
  3. Article
  4. Review
  5. Antler cannibalism in reindeer.Scientific reports · 2020
    Article
  6. Prion-like mechanisms in Alzheimer disease.Handbook of clinical neurology · 2018
    Review
  7. Review
  8. Article
  9. Article
  10. Crystallization and preliminary X-ray diffraction analysis of a specific VHH domain against mouse prion protein.Acta crystallographica. Section F, Structural biology and crystallization communications · 2010
    Article
  11. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  12. Article
  13. Article
  14. Inducible proteopathies.Trends in neurosciences · 2006
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. GroEL-mediated protein folding: making the impossible, possible.Critical reviews in biochemistry and molecular biology
    Review
  20. Prions in dentistry: A need to be concerned and known.Journal of oral and maxillofacial pathology : JOMFP
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Edward McKintoshDepartment of Neurodegenerative Disease/MRC Prion Unit, Institute of Neurology, University College London, London, United Kingdom.
Sarah J Tabrizi
John Collinge

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prion diseases are incurable neurodegenerative conditions affecting both animals and humans. They may be sporadic, infectious, or inherited in origin. Human prion diseases include Creutzfeldt-Jakob desease (CJD), Gerstmann-Straussler-Scheinker disease, kuru, and fatal familial insomnia. The appearance of variant CJD, and the demonstration that is caused by strains indistinguishable from bovine spongiform encephalopathy (BSE) in cattle, has led to the threat of a major epidemic of human prion disease in the UK and other countries where widespread dietary exposure to bovine prions has occurred. This article reviews the history and epidemiology of these diseases, and then focuses on important areas of current research in human prion disorders.

Indexed as

AnimalsHumansPrion DiseasesPrionsSpecies SpecificityPrions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.